- Consumer Products
- Latest 20.39
- Currency US$
- Change -0.42
- Percent Change -2.018 %
- Volume 1,415,023
- Wed May 22, 2013 4:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||May 7||$-0.03||Aug 5||$-0.30|
12 months ended May 22, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Isis Pharmaceuticals, Inc. is a leading genomics-based drug discovery and development company that is focused on RNA. RNA is a novel target for drug discovery, and Isis has established a dominant position in RNA research. The company has integrated the expertise in molecular and cellular biology, medicinal chemistry, RNA biochemistry, bioinformatics, pharmacology and clinical development to create two exciting technologies, antisense and Ibis, a robust pipeline of drugs in development and genomics services.